Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Aetna Inc    AET

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Goldman M&A head Sykes joins management committee

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/19/2012 | 11:07pm CET

Gene Sykes, global head of Goldman Sachs Group Inc's (>> Goldman Sachs Group, Inc.) mergers and acquisitions business, has been named to the investment bank's management committee, according to an internal memo.

Gene Sykes, global head of Goldman Sachs Group Inc's (>> Goldman Sachs Group, Inc.) mergers and acquisitions business, has been named to the investment bank's management committee, according to an internal memo.

The 54-year-old investment banker joins 28 other executives on the powerful committee, which includes Chief Executive Lloyd Blankfein and Chief Operating Officer Gary Cohn, and influences decisions about Goldman's business strategy and operations.

Sykes' appointment comes just nine days after the departure of another prominent Goldman banker, Yoel Zaoui, was announced in a separate internal memo. Zaoui shared the title of M&A co-head with Sykes and had also been on the management committee.

Sykes, who is based in Los Angeles, is also chairman of the global technology, media and telecommunications department of the investment banking division. He is a member of Goldman's internal Business Standards Committee.

The Goldman veteran joined the firm in 1984 and became a partner in 1992. He has advised on several high-profile deals, including Walt Disney Co's (>> The Walt Disney Company) acquisition of Pixar, Aetna Inc's (>> Aetna Inc.) acquisition of U.S. Healthcare and Roche Holding AG acquisition of Genentech.

"Gene has played a vital role in strengthening our investment banking franchise, particularly with respect to many of the most significant companies in technology and media," Blankfein and Cohn said in the memo, whose contents were confirmed by a spokesman.

(Reporting By Lauren Tara LaCapra in New York; editing by Andre Grenon)

By Lauren Tara LaCapra

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AETNA INC
01/18 AETNA : Allina Health and Aetna Agree to Establish New Partnership in Minnesota
01/18DJMore Women Are Winning CEO Job -- WSJ
01/18 AETNA : to Announce Fourth-Quarter and Full-Year 2016 Results
01/17DJWomen Make Gains Toward Winning CEO Job
01/10 AETNA INC : ex-dividend day
2016DJAETNA : Humana Defend Merger as Justice Department Warns It Would Harm Consumers
2016 MIMEDX : Aetna Inc Grants Coverage for EpiFix Diabetic Foot Ulcer Treatment
2016 AETNA INC. (NYSE : AET) Files An 8-K Entry into a Material Definitive Agreement
2016DJDonald Trump's Pick for Health Secretary Traded Medical Stocks While in House
2016 HUMANA INC. (NASDAQ : HUM) Files An 8-K Entry into a Material Definitive Agreeme..
More news
Sector news : Managed Healthcare - NEC
01/18DJLower Oil Prices Drag on Energy Stocks
01/18DJUNITEDHEALTH : Says ACA Drag Is Easing -- WSJ
01/17DJUNITEDHEALTH : Revenue, Profit Tops Forecasts
01/17DJAHEAD OF THE TAPE : Insurer Is Set to Pass Its Exam -- WSJ
01/16DJUNITEDHEALTH : Is Poised to Pass Its Earnings Checkup--Ahead of the Tape
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
01/16 Trump vows health 'insurance for everybody'
01/12 Aetna Launches $200m Vitality Re VIII Health Insurance Linked ILS
01/12 WALL STREET BREAKFAST : Apple Sets Its Sights On Hollywood
01/12 Senate takes first step to repeal Obamacare
01/05 Stocks Going Ex-Dividend The Second Week Of January
Advertisement
Financials ($)
Sales 2016 63 185 M
EBIT 2016 4 784 M
Net income 2016 2 605 M
Debt 2016 4 521 M
Yield 2016 0,82%
P/E ratio 2016 16,63
P/E ratio 2017 14,92
EV / Sales 2016 0,74x
EV / Sales 2017 0,73x
Capitalization 42 448 M
More Financials
Chart AETNA INC
Duration : Period :
Aetna Inc Technical Analysis Chart | AET | US00817Y1082 | 4-Traders
Full-screen chart
Technical analysis trends AETNA INC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 140 $
Spread / Average Target 16%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Mark T. Bertolini Chairman & Chief Executive Officer
Karen S. Lynch President
Margaret M. McCarthy Executive Vice President-Operations & Technology
Shawn M. Guertin CFO, Executive VP & Chief Enterprise Risk Officer
Harold L. Paz Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AETNA INC-2.45%42 473
UNITEDHEALTH GROUP INC-1.44%152 919
ANTHEM INC2.40%38 659
CIGNA CORPORATION6.43%37 168
HUMANA INC1.02%30 423
CENTENE CORP11.25%10 780
More Results